von Willebrand disease

Blood disorders & Cancer

von Willebrand disease

VWD

Von Willebrand disease (VWD) is the most common inherited bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor (VWF), a protein that helps blood clot. It affects both men and women and can lead to symptoms like easy bruising, frequent nosebleeds, heavy menstrual bleeding, and prolonged bleeding after injury or surgery.

There are three main types: Type 1 (mild, partial deficiency), Type 2 (moderate, abnormal function), and Type 3 (severe, almost no VWF). Diagnosis involves blood tests that measure VWF levels and function.

Treatment depends on the type and severity and may include desmopressin (to release stored VWF), VWF replacement therapy, or antifibrinolytics. Most people with VWD can manage the condition with proper medical care and precautions.

AI Summary of Treatment Experiences

Not medical advice.

The treatment landscape for von Willebrand disease (VWD) primarily involves the use of medications such as aminocaproic acid, tranexamic acid, recombinant VWF, and various factor VIII concentrates like Alphanate, Wilate, and Humate-P. Desmopressin is considered the first-line therapy for type 1 VWD and some type 2 cases, given the patient's responsiveness. The choice of treatment depends on the severity and type of VWD, with more severe cases (type 2B or type 3) or situations requiring surgical preparation, active bleeding treatment, or trauma management necessitating the use of factor concentrates like Humate-P.

Treatments
Compare

4 Treatments for von Willebrand disease

Add new treatment

Prescription Medication

Tranexamic acid

Lysteda

5.0 (2)

Prescription Medication

Desmopressin

DDAVP

4.5 (2)

Prescription Medication

Aminocaproic acid

— (0)

Prescription Medication

Recombinant VWF

Vonvendi

— (0)

Choose treatments from the menu above to see how they compare side by side.